NCT05498753

Brief Summary

A Longitudinal Study of Function, ADL, and Quality of life of Patients with Developmental Disabilities

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 12, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

February 21, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

August 12, 2022

Status Verified

February 1, 2022

Enrollment Period

1.9 years

First QC Date

February 17, 2022

Last Update Submit

August 10, 2022

Conditions

Keywords

Body function and body structureParticipationLife activitiesQuality of Life

Outcome Measures

Primary Outcomes (5)

  • Change from baseline general development for Healthy child and preterm infants at 6 months 1

    Bayley scales of infant and Toddler Developmentfourth edition is used to examine the body function, motor function, cognitive, language, and social behavior. (Scores from 0 to 140, higher scores mean a better outcome.)

    From 6 months to 4 years

  • Change from baseline general development for Healthy child and preterm infants at 6 months 2

    Comprehensive Development Inventory for Infant and Toddlers (CDIIT) is used to examine the body function, motor function, cognitive, language, and social behavior. (Higher scores mean a better outcome.)

    From 6 months to 4 years

  • Change from baseline general development for Healthy child and preterm infants at 6 months 3

    Hawaii Early Learning Profile (HELP) is used to examine the regulatory/sensory orginization, motor function, cognitive, language, and social behavior, and self-help. (Higher scores mean a better outcome.)

    From 6 months to 4 years

  • Change from baseline general development for Healthy child and preterm infants at 6 months 4

    General Movements Assessment (GMA) is used to examine the motor function. (Higher scores mean a better outcome.)

    From 6 months to 4 years

  • Change from baseline functions for preterm infants at 6 months

    PREMature Infant Index(PREMII) is used to examine the respiratory support, oxygen administration, apnea, bradycardia, desaturation, thermoregulation, feeding, and weight. (Higher scores mean a better outcome.)

    From 6 months to 4 years

Study Arms (2)

Control

Healthy infants

Experimental

Preterm Infants

Eligibility Criteria

Age6 Months - 3 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Enroll preterm and healthy infants.

You may qualify if:

  • Children who were born before 37 weeks
  • Age 0-3 y/o
  • Agree to sign inform consent

You may not qualify if:

  • Active medical condition (e.g. infection)
  • Concurrent disease which affect nuerological development, such as cerebral palsy, or other disease not typically associated with preterm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Chia-Ling Chen

    Chang Gung Memorial Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2022

First Posted

August 12, 2022

Study Start

February 21, 2023

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

August 12, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations